The AHA today urged the Centers for Medicare & Medicaid Services to immediately withdraw the new condition of participation that threatens to expel hospitals from the Medicare program if they fail to comply with “frequently changing and confusing” COVID-19 data collection efforts.

“CMS’ decision to threaten hospital Medicare participation is a direct rebuke of the clear willingness displayed by America’s hospitals and health systems to provide all relevant data to the federal government,” AHA said today in comments on the agency’s Aug. 25 interim final rule. “It threatens not only to negatively impact the collaborative work in which our members have engaged, but also needlessly jeopardizes the financial viability of hospitals across the country on which millions of Americans rely. The previous success of COVID-19 data reporting was built on partnerships not mandates; the agency should continue along this path and reject pursing this unnecessary approach to COVID-19 data reporting. In moving forward with this interim final rule, the agency is abandoning collaboration and teamwork for a heavy-handed regulatory approach.”

In addition, the AHA said it opposes CMS’ policy of making the reporting of COVID-19 testing data a CoP for laboratories and urged the agency “to rescind this CoP, or at a minimum, to rescind the rule’s provisions imposing civil monetary penalties on labs for non-compliance.”

The AHA also commented on provisions in interim final rule related to changes to quality measurement requirements; nursing home provisions and limits on COVID-19 testing.

Related News Articles

Headline
In a letter submitted July 2 to the Centers for Medicare & Medicaid Services on guidance for the Medicare Drug Price Negotiation Program, the AHA expressed…
Headline
The Centers for Medicare & Medicaid Services June 28 released a proposed rule on mitigating the impact of significant, anomalous and highly suspect (SAHS)…
Headline
The Department of Health and Human Services June 26 announced beneficiary coinsurance reductions for 64 prescription drugs available through Medicare Part B.…
Perspective
For too long and for too many patients, the process of obtaining prior authorization for a medical procedure or medicine has been a tangled web, as people are…
Headline
The AHA June 14 sent a letter to the Senate Finance Committee, responding to questions included in a white paper the committee wrote on chronic care through…
Headline
The Centers for Medicare & Medicaid Services estimates national health spending grew 7.5% in 2023, reflecting increases in insurance growth, the agency…